Recent advances of novel targeted therapy in non-small cell lung cancerNovel agents for chronic lymphocytic leukemiaB-Raf and the inhibitors: from bench to bedsideTargeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancersAlternative expression of TCRζ related genes in patients with chronic myeloid leukemiaLight chain (AL) amyloidosis: update on diagnosis and managementClinical applications of mesenchymal stem cellsRetinoic acid induces HL-60 cell differentiation via the upregulation of miR-663Novel histone deacetylase inhibitors in clinical trials as anti-cancer agentsEpigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biologyDysregulation of miR-15a and miR-214 in human pancreatic cancerTargeting tumorigenesis: development and use of mTOR inhibitors in cancer therapyMechanism of action of lenalidomide in hematological malignanciesALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literatureFirst-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meetingDownstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implicationsElotuzumab for the treatment of multiple myelomaEGFR C797S mutation mediates resistance to third-generation inhibitors in T790M-positive non-small cell lung cancerTargeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectivesCurrent status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapyDaratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myelomaNovel agents in the treatment of multiple myeloma: a review about the futureThe clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantationThird-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancerTherapeutic options in peripheral T cell lymphomaHow do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?Bispecific antibodies and their applicationsPersistent androgen receptor addiction in castration-resistant prostate cancerThe roles of stem cell memory T cells in hematological malignanciesBlinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemiaDrugging the unfolded protein response in acute leukemiasRole of DNA methylation in renal cell carcinomaNon-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancerAdvances in the management of gastrointestinal cancers--an upcoming role of immune checkpoint blockadeOvarian serous carcinoma: recent concepts on its origin and carcinogenesisEndothelial progenitor cells in ischemic stroke: an exploration from hypothesis to therapyThe roles of mesenchymal stem cells in tumor inflammatory microenvironmentBiomarkers for determining the prognosis in chronic myelogenous leukemiaHeritable GATA2 mutations associated with familial AML-MDS: a case report and review of literatureNovel agents and biomarkers for acute lymphoid leukemia
P1433
Q21092930-FEC1283A-E946-4EF2-9DE8-F58D96878BB7Q21198858-776C1DB9-5B4E-418C-B4F6-DFF028646FBBQ21198860-7CD6B577-ACEE-40B8-B973-FE3F44F5CA6BQ21198861-FA0E9F64-A66B-4844-8974-EE89191C8417Q21198862-50708868-FCC8-4D44-91E9-826E52E11C12Q21198863-436E6CFE-5788-4302-8771-2818E95EB741Q21198864-2081E802-4716-4032-B0F6-9AD8A3B3A64AQ21198866-D692A816-25D4-4AC9-8E2F-9BA101D8F8BDQ21198868-B504D090-DD7B-4A73-8BC3-EF57FE23D854Q21198869-5ADF9EBE-03CF-4C8A-9E20-0F30A5784159Q21198870-BD0CB195-05E3-40D2-8FA9-7E1DB4A8E36DQ21198871-B52CFC94-EBEF-40E7-AE35-5F98A66D9740Q21198872-FF19ACAF-D7D9-414B-A649-D7B54EF045C2Q21198873-DDB6C617-CF4D-4598-AB93-B3FE112D0E0AQ21198874-5C5D2308-5520-4E1E-8992-17CD5AF4AE89Q24617091-F3A53141-EF3C-4D7B-9158-DD6A310B3E43Q26740278-1122FE91-74AF-4902-8E48-C9BD91835841Q26741998-F56A29E7-62DA-4E64-A9E8-3471246484C4Q26744441-E30B9D97-1751-469A-B9C5-B4EADAD74DC4Q26745516-380FF1F3-B403-45EE-AC6F-E08FA54BB20AQ26745919-C84CA6CE-BADC-49F3-9961-C31EAF482A02Q26745924-021FA9C4-C508-4458-BC23-5228D5C5D4F4Q26748595-7F961D64-6499-4B5A-A99E-0106558325C1Q26748851-0002084B-3240-4B83-A2DA-132E33420DD8Q26748857-318E581D-4395-416B-B66B-05EC908E9E95Q26748867-445817F1-A367-48D5-8CA5-FE48DC390BB8Q26774024-381C7515-2D30-40A9-BBD5-A490BB2279FEQ26777163-C43B189A-CC1E-4E6C-82AC-1FC7848332C8Q26783681-52150485-231E-4A8A-9B4B-EF1C59925D94Q26785828-41BD721D-1E99-4179-8D98-D098E61F817DQ26801114-A5EA16D1-503D-4F68-8447-2D68A4225630Q26801268-DC723630-E586-462B-832B-C97AF45BDEFEQ26801357-18594831-957D-4C0B-B61F-E8B6B3DBFF3CQ26801856-A201F3B9-A06E-406E-8F23-A48448BE9014Q26822545-E4FD521C-0600-4ABD-A8C0-56505513908BQ26823609-C84EBA1B-FB5A-4D94-B634-DD37AB83A9D3Q26823759-52278260-8F20-4CDC-A0F7-5797E765AC3DQ26824660-084275EA-56EA-471D-B911-8E98ABE48ABCQ26828941-E8C2C062-AD8A-48C7-95BE-F9BC14F553DCQ26829775-9AF945D1-180B-47B0-A231-8DB6665C6370
P1433
description
publikation
@de
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
scientific journal
@en
vědecký časopis
@cs
wetenschappelijk tijdschrift van BioMed Central
@nl
науковий журнал
@uk
مجلة
@ar
वैज्ञानिक पत्रिका
@hi
name
Journal of Hematology & Oncology
@ast
Journal of Hematology & Oncology
@de
Journal of Hematology & Oncology
@en
Journal of Hematology & Oncology
@es
Journal of Hematology & Oncology
@fr
Journal of Hematology & Oncology
@it
Journal of Hematology & Oncology
@nl
type
label
Journal of Hematology & Oncology
@ast
Journal of Hematology & Oncology
@de
Journal of Hematology & Oncology
@en
Journal of Hematology & Oncology
@es
Journal of Hematology & Oncology
@fr
Journal of Hematology & Oncology
@it
Journal of Hematology & Oncology
@nl
altLabel
Journal of Hematology and Oncology
@en
prefLabel
Journal of Hematology & Oncology
@ast
Journal of Hematology & Oncology
@de
Journal of Hematology & Oncology
@en
Journal of Hematology & Oncology
@es
Journal of Hematology & Oncology
@fr
Journal of Hematology & Oncology
@it
Journal of Hematology & Oncology
@nl
P31
P3181
P1055
P1058
P1156
17900156736
P123
P1277
P1476
Journal of Hematology & Oncology
@en
P166
P236
P407
P5115
P571
2008-01-01T00:00:00Z